As consumer demand for high-quality over-the-counter (OTC) skincare continues to surge, the 2025-2026 U.S. News & World Report rankings for Best OTC Medicine & Health Products provide valuable insight into the products dermatologists are most likely to recommend.
Developed with The Harris Poll, this annual report reflects expert assessments from 357 pharmacists and 134 dermatologists across 133 categories, including many dermatologic staples.
CeraVe, Neutrogena, and La Roche-Posay: A Trusted Trio
Leading the skincare pack once again are CeraVe and Neutrogena, followed closely by La Roche-Posay. These brands earned the most No. 1 product rankings in dermatology-related categories, reinforcing their widespread credibility and therapeutic value. As patient preferences shift toward accessible, evidence-based skincare, these products are increasingly becoming mainstays in dermatologist recommendations.
This year’s top picks, evaluated on safety, efficacy, affordability and accessibility, include:
- Face Moisturizers: La Roche-Posay
- Face Washes for Sensitive Skin: CeraVe
- Lip Balms: Aquaphor
- Retinol Creams & Serums: Neutrogena
- Stretch Mark Treatments: Mederma
- Facial Sunscreens: La Roche-Posay
- Hair Growth Vitamins (Women): Nutrafol
- Wrinkle Creams: Neutrogena
For dermatologists, these results affirm the growing alignment between clinical judgment and public trust in OTC brands – especially when affordability and adherence are in question.
Clinical Implications: Bridging Consumer Confidence and Physician Guidance
The convergence of dermatologist-backed products and consumer satisfaction reflects a shift toward what might be called “accessible dermatology.” As patients become more proactive in managing their skin health, these product rankings offer an opportunity for physicians to guide patient behavior in a positive, evidence-based direction.
For clinicians, this trend translates to greater confidence when recommending OTC products as adjuncts to prescription regimens or as frontline solutions for mild-to-moderate conditions.
Key Takeaway: OTC Skincare Is No Longer Secondary
Once viewed as supplemental, OTC skincare is now an essential component of modern dermatologic care. The 2025–2026 rankings underscore a shift towards affordability, accessibility, and clinical validation—equipping dermatologists with new tools to support long-term skin health and stronger patient relationships.
